Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and improved medicines utilizing Nanoform’s platform technologies. The company focuses on reducing attrition in clinical trials and on enhancing drug molecules’ formulation performance through its nanoforming services. Nanoform’s capabilities span the small to large molecule development space and the company focuses on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications.
Tackling Bioavailability Challenges
Nanoform CCO Christian Jones explains the opportunities for using nanotechnology to increase drug development efficiency and create better medicines for patients.
Paving The Way For Tomorrow’s Medicines
Nanoparticle Engineering White Paper
Interested in seeing our state of the art facility? View the video for more information.
Global experts in
drug particle engineering
Nanoform has attracted talented individuals from across the globe.
Vice President Business Development
Christian Jones, FRSC
Chief Commercial Officer (CCO)
Vice President of Business Development
Gonçalo Rebelo de Andrade, PhD MBA
Chief of Business Operations
Chief Technology Officer (CTO)
FI-00790 Helsinki Finland
+358 29 370 0150